IN2012DN00624A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN00624A IN2012DN00624A IN624DEN2012A IN2012DN00624A IN 2012DN00624 A IN2012DN00624 A IN 2012DN00624A IN 624DEN2012 A IN624DEN2012 A IN 624DEN2012A IN 2012DN00624 A IN2012DN00624 A IN 2012DN00624A
- Authority
- IN
- India
- Prior art keywords
- fatigue
- treatments
- diseases
- prevention
- compositions
- Prior art date
Links
- 238000011282 treatment Methods 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
- A61K31/175—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21908209P | 2009-06-22 | 2009-06-22 | |
| PCT/US2010/039313 WO2011005473A2 (en) | 2009-06-22 | 2010-06-21 | Methods for treating or preventing fatigue |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN00624A true IN2012DN00624A (enrdf_load_html_response) | 2015-06-12 |
Family
ID=43429751
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN624DEN2012 IN2012DN00624A (enrdf_load_html_response) | 2009-06-22 | 2010-06-21 |
Country Status (13)
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006254899B2 (en) | 2005-06-08 | 2011-11-24 | Sk Biopharmaceuticals Co., Ltd. | Treatment of sleep-wake disorders |
| CA2765463C (en) | 2009-06-22 | 2018-10-09 | Moise A. Khayrallah | Methods for treating or preventing fatigue |
| AU2010316106B2 (en) | 2009-11-06 | 2015-10-22 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating attention-deficit/hyperactivity disorder |
| ES2743153T3 (es) * | 2009-11-06 | 2020-02-18 | Sk Biopharmaceuticals Co Ltd | Métodos para tratar el síndrome de fibromialgia |
| US9610274B2 (en) | 2010-06-30 | 2017-04-04 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating bipolar disorder |
| US8623913B2 (en) | 2010-06-30 | 2014-01-07 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating restless legs syndrome |
| EP2670406B1 (en) * | 2011-12-21 | 2015-09-02 | InnoBioscience, LLC | Combination therapy with interferon beta and andrographolides for multiple sclerosis |
| RU2689984C2 (ru) | 2013-03-13 | 2019-05-30 | ЭРИЭЛ БАЙОФАРМА, ЭлЭлСи | Лечение катаплексии |
| KR20210152011A (ko) * | 2013-07-12 | 2021-12-14 | 에스케이바이오팜 주식회사 | 금연의 촉진 |
| JP6529495B2 (ja) | 2013-07-18 | 2019-06-12 | ジャズ ファーマスティカルズ インターナショナル スリー リミテッドＪａｚｚ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｉｉ Ｌｉｍｉｔｅｄ | 肥満の治療 |
| WO2015067759A1 (en) * | 2013-11-08 | 2015-05-14 | Legacy Healthcare Ltd | Method for the management of cancer and treatment of cancer comorbidities |
| US10888542B2 (en) | 2014-02-28 | 2021-01-12 | Sk Biopharmaceuticals Co., Ltd. | Aminocarbonylcarbamate compounds |
| TWI698415B (zh) | 2014-02-28 | 2020-07-11 | 南韓商愛思開生物製藥股份有限公司 | 胺基羰基胺基甲酸酯化合物 |
| US10195151B2 (en) | 2016-09-06 | 2019-02-05 | Jazz Pharmaceuticals International Iii Limited | Formulations of (R)-2-amino-3-phenylpropyl carbamate |
| JP7219213B2 (ja) | 2016-09-06 | 2023-02-07 | ジャズ ファーマスティカルズ アイルランド リミテッド | （ｒ）－２－アミノ－３－フェニルプロピルカルバメートの溶媒和物フォーム |
| EP3523275B1 (en) | 2016-10-06 | 2023-09-27 | Axsome Malta Ltd. | Carbamoyl phenylalaninol compounds for medical use |
| CN110139905B (zh) * | 2016-12-30 | 2021-09-28 | 株式会社东进世美肯 | 涂层组合物及由此制备的薄膜 |
| NZ760594A (en) | 2017-06-02 | 2025-05-02 | Jazz Pharmaceuticals Ireland Ltd | Methods and compositions for treating excessive sleepiness |
| CN111094238B (zh) | 2017-07-31 | 2023-06-09 | 杰资制药爱尔兰有限公司 | 氨基甲酰基苯丙氨醇类似物及其用途 |
| JP7428480B2 (ja) * | 2019-06-06 | 2024-02-06 | 雪印メグミルク株式会社 | 睡眠改善用組成物及び組成物を含む食品、医薬品、飼料 |
| US10940133B1 (en) | 2020-03-19 | 2021-03-09 | Jazz Pharmaceuticals Ireland Limited | Methods of providing solriamfetol therapy to subjects with impaired renal function |
| KR102390194B1 (ko) | 2020-08-03 | 2022-04-25 | 셀라이온바이오메드 주식회사 | 페닐알킬 카바메이트 화합물을 포함하는 Kca3.1채널 매개질환 치료용 조성물 |
| AU2022390879A1 (en) * | 2021-11-16 | 2024-06-13 | Axsome Malta Ltd. | Methods and compositions for treating cognitive impairment |
| WO2025006965A1 (en) | 2023-06-29 | 2025-01-02 | Axsome Therapeutics, Inc. | Methods of administering solriamfetol to lactating women |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ314570A (en) | 1993-06-10 | 2000-11-24 | Lilly Co Eli | Treatment of emesis using tetrahydrobenz[cd]indole-6-carboxamides |
| KR100197892B1 (ko) * | 1994-09-09 | 1999-06-15 | 남창우 | 신규한 페닐알킬아미노 카바메이트 화합물과 그의 제조방법 |
| KR0173862B1 (ko) | 1995-02-11 | 1999-04-01 | 조규향 | O-카바모일-(d)-페닐알라닌올 화합물과 그의 약제학적으로 유용한 염 및 이들의 제조방법 |
| US5756817C1 (en) | 1995-02-11 | 2001-04-17 | Sk Corp | O-carbamoyl-phenylananinol compounds their pharmaceutically useful salts and process for preparing the same |
| KR0173863B1 (ko) * | 1995-04-10 | 1999-04-01 | 조규향 | 페닐에 치환체가 있는 o-카바모일-페닐알라닌올 화합물과 그의 약제학적으로 유용한 염 및 이들의 제조방법 |
| AU4567597A (en) | 1996-10-08 | 1998-05-05 | Institute Of Child Health | Mutant ciita molecule and uses thereof |
| CN1076016C (zh) * | 1996-10-10 | 2001-12-12 | Sk株式会社 | O－氨基甲酰基－苯丙胺醇化合物、其药学上有用的盐和它们的制备方法 |
| AU4674797A (en) | 1996-10-22 | 1998-05-15 | Ortho Pharmaceutical Corporation | Phenylalaninol derivatives for the treatment of central nervous system disorders |
| US20040229951A1 (en) | 2003-05-15 | 2004-11-18 | Arthur Vanmoor | Method of treating fatigue by enhancing the effectiveness of the human immune system |
| RU2267319C2 (ru) * | 2003-07-15 | 2006-01-10 | Общество с ограниченной ответственностью "Интер-Кэр" | Фармацевтическая композиция и способ лечения синдрома хронической усталости с ее использованием |
| US20050080268A1 (en) | 2003-10-08 | 2005-04-14 | Yong-Moon Choi | Process of preparing O-carbamoyl compounds in the presence of active amine group |
| AU2005302589B2 (en) | 2004-10-28 | 2010-09-16 | Sk Biopharmaceuticals Co., Ltd. | Adjunctive therapy for depression |
| AU2006254899B2 (en) * | 2005-06-08 | 2011-11-24 | Sk Biopharmaceuticals Co., Ltd. | Treatment of sleep-wake disorders |
| EP1893291B1 (en) | 2005-06-22 | 2010-03-03 | SK Holdings Co., Ltd. | Treatment of sexual dysfunction |
| CA2616721C (en) | 2005-07-26 | 2014-01-21 | Janssen Pharmaceutica N.V. | Methods for treating substance-related disorders |
| CN101557804A (zh) | 2006-10-13 | 2009-10-14 | 詹森药业有限公司 | 氨基甲酸苯基烷基氨基酯组合物 |
| CA2765463C (en) | 2009-06-22 | 2018-10-09 | Moise A. Khayrallah | Methods for treating or preventing fatigue |
| US8232315B2 (en) | 2009-06-26 | 2012-07-31 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating drug addiction and improving addiction-related behavior |
| ES2743153T3 (es) | 2009-11-06 | 2020-02-18 | Sk Biopharmaceuticals Co Ltd | Métodos para tratar el síndrome de fibromialgia |
| AU2010316106B2 (en) | 2009-11-06 | 2015-10-22 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating attention-deficit/hyperactivity disorder |
| US8623913B2 (en) | 2010-06-30 | 2014-01-07 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating restless legs syndrome |
| US9610274B2 (en) | 2010-06-30 | 2017-04-04 | Sk Biopharmaceuticals Co., Ltd. | Methods for treating bipolar disorder |
| RU2689984C2 (ru) * | 2013-03-13 | 2019-05-30 | ЭРИЭЛ БАЙОФАРМА, ЭлЭлСи | Лечение катаплексии |
| JP6215740B2 (ja) * | 2014-03-14 | 2017-10-18 | 本田技研工業株式会社 | 部品の締結構造 |
-
2010
- 2010-06-21 CA CA2765463A patent/CA2765463C/en not_active Expired - Fee Related
- 2010-06-21 KR KR1020197026173A patent/KR102173587B1/ko active Active
- 2010-06-21 CN CN2010800277527A patent/CN102481274A/zh active Pending
- 2010-06-21 IN IN624DEN2012 patent/IN2012DN00624A/en unknown
- 2010-06-21 AU AU2010270971A patent/AU2010270971B2/en active Active
- 2010-06-21 EP EP10797541.9A patent/EP2445490B1/en active Active
- 2010-06-21 WO PCT/US2010/039313 patent/WO2011005473A2/en active Application Filing
- 2010-06-21 KR KR1020127001795A patent/KR20120098578A/ko not_active Ceased
- 2010-06-21 RU RU2012101947/15A patent/RU2567801C2/ru active
- 2010-06-21 MX MX2012000034A patent/MX2012000034A/es active IP Right Grant
- 2010-06-21 US US13/379,793 patent/US8741950B2/en active Active
- 2010-06-21 BR BRPI1015233A patent/BRPI1015233A2/pt not_active Application Discontinuation
- 2010-06-21 JP JP2012517622A patent/JP6095366B2/ja active Active
- 2010-06-21 KR KR1020177020249A patent/KR102021075B1/ko active Active
- 2010-06-21 CN CN201710080968.3A patent/CN106727486A/zh active Pending
- 2010-06-22 TW TW099120382A patent/TWI453014B/zh active
-
2014
- 2014-05-07 US US14/271,503 patent/US9464041B2/en active Active
-
2015
- 2015-07-03 JP JP2015134556A patent/JP6368285B2/ja active Active
-
2016
- 2016-09-16 US US15/268,060 patent/US9999609B2/en active Active
-
2018
- 2018-05-18 US US15/983,944 patent/US10507192B2/en active Active
- 2018-07-05 JP JP2018128318A patent/JP2018188450A/ja active Pending
-
2019
- 2019-10-31 US US16/670,382 patent/US20200061017A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN00624A (enrdf_load_html_response) | ||
| IN2012DN03883A (enrdf_load_html_response) | ||
| MX351464B (es) | El uso de un agonista del receptor 8 tipo toll para el tratamiento de enfermedades alérgicas. | |
| MX364200B (es) | Composiciones y metodos novedosos para el tratamiento de las enfermedades relacionadas con la inmunidad. | |
| MY172372A (en) | Compositions and methods for lowering triglycerides | |
| UA108198C2 (uk) | Заміщені 2-ацетамідо-5-арил-1,2,4-триазолони та їх застосування | |
| NZ727304A (en) | Compositions and methods of use of phorbol esters for the treatment of stroke | |
| EP2294184A4 (en) | TREATMENT OF EYE DISEASES AND EXCESSIVE NEOVASCULARIZATION WITH THE HELP OF COMBINED THERAPY | |
| MX2011007930A (es) | Conjugados de insulina cristalina. | |
| MY161495A (en) | Virus like particle compositions and methods of use | |
| IN2012DN02471A (enrdf_load_html_response) | ||
| IN2012DN02081A (enrdf_load_html_response) | ||
| ZA201304638B (en) | Composition for use in the prevention and /or treatment of skin condition and skin diseases. | |
| AU2011338383A8 (en) | Treatment of HER2-positive cancer with paclitaxel and trastuzumab-MCC-DM1 | |
| MX343135B (es) | Compuestos de tipo fumagilol y métodos de realización y uso de los mismos. | |
| MY178905A (en) | Prevention, treatment and diagnosis of p.gingivalis infection | |
| TN2011000482A1 (en) | Organic compounds and their uses | |
| MX2009009761A (es) | Composiciones y estuches para tratamiento de la influenza. | |
| MX2009013353A (es) | Compuestos activadores de telomerasa y metodos para su uso. | |
| TNSN08400A1 (en) | Organic compounds and their uses | |
| UA107204C2 (uk) | Протигрибкова композиція, що містить грибковий організм pythium oligandrum | |
| MX342947B (es) | Tratamiento de diabetes tipo 2. | |
| WO2013098416A3 (fr) | Composes anti-douleur | |
| EP2585067A4 (en) | COMPOUND FOR THE TREATMENT OF ENTEROVIRUS | |
| MY150931A (en) | Substituted oxazolidinones and their use |